If it were up to me, I'd select the subset of samples with the most
extensive phenotype data — biomarkers, clinical measurements, RNA - seq, health records, etc..
On October 5, 2005, NIH announced that contracts had been signed with two companies, Deltagen, Inc. and Lexicon Genetics, Inc., to provide knockout mouse lines and
extensive phenotyping data on them to NIH.
On October 5, 2005, NIH announced that contracts had been signed with two companies, Deltagen, Inc. and Lexicon Genetics, Inc. (now Lexicon Pharmaceuticals), to provide knockout mouse lines and
extensive phenotyping data on them to NIH.